Indinavir (Crixivan)

The Clinical Pharmacology section of the Crixivan (indinavir) label has been revised to include pharmacokinetic data from a study (PACTG 358) in HIV-infected pregnant women. Results from this study show substantially reduced indinavir concentrations ...

Background

Disturbingly few studies to date have focused on the potential impact of vitamins, minerals, herbal medicines and other supplements on the blood plasma levels of HIV antiretrovirals, particularly protease inhibitors. There are any number ...

Lack of Clinically Relevant Drug-Drug Interactions Between Tenofovir DF and Efavirenz, Indinavir, Lamivudine and Lopinavir/Ritonavir in Healthy Subjects (Oral Session 3, Abstract 171) Authored by B. Kearney, J. Flaherty, J. Wolf, et al.

Tenofo...

Differential In Vitro Effects of Indinavir, Nelfinavir and Amprenavir On Cell Differentiation, Insulin Sensitivity and Apoptosis In an Adapted Adipose Cell Model -- Preventive Impact of Rosiglitazone Presenter: Jacqueline Capeau

This interesti...

The most well-known side effects linked to the use of the protease inhibitor indinavir (Crixivan) are kidney pain, kidney dysfunction and kidney stones. Now researchers in Italy think that high blood pressure may also be another side effect.

Doctors...

Preliminary Results from Indinavir (IDV) and Ritonavir (RTV) in a Once-Daily Regimen (Marck 103/104) (Poster 336) Authored by J. Suleiman, R. Rhodes, R. Campo, P. Piliero, R. Steigbigel, J. Chen, G. Winchell, and A. SaahView the original abstra...